Status:

COMPLETED

Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Venous Disease

Venous Vascular Diseases and Syndromes

Eligibility:

All Genders

21+ years

Phase:

PHASE1

PHASE2

Brief Summary

Leg vein circulation problems can damage the skin of the lower legs, especially around the ankles, by making it discolored, hard, itchy, red, and swollen. Ulcers often develop. Inflammation is often p...

Detailed Description

This new trial will assess the efficacy of this home-based cryotherapy intervention by adding sequenced tapered cooling after a 30-day intense cooling period. The goal is to reduce skin blood flow of ...

Eligibility Criteria

Inclusion

  • aged 21 years or older
  • CEAP Classification: Stage C4 (skin damage) and 5 (healed VLU) - leg ulcer healed within past month with intact epithelium
  • history of healed VLU within past 2 years
  • ankle brachial index (ABI) 0.80 - 1.3 mmHG, absence of peripheral arterial disease
  • intact skin sensation
  • intact thermal sensation
  • agreement to ear compression during waking hours
  • phone, email or mail accessible
  • willingness to make 5 study visits including baseline
  • able to understand protocol by passing test after watching DVD standardized instructions for low literacy
  • able to perform required protocol activities
  • ability to speak English

Exclusion

  • diagnosed arterial disease or ABI \<0.80 or \>1.3 mm Hg (blood flow to the skin is reduced in arterial disease and cooling could cause tissue ischemia)
  • surgical procedures on leg in past 1 year (can affect venous circulation/cause edema)
  • open leg/foot ulcers
  • recent leg infection within past month (increased inflammation)
  • impaired cognitive status (cannot perform procedures)
  • chronic inflammatory and vascular conditions where blood flow of the skin may be impacted such as Lupus erythematosus, lymphedema, Raynaud's, rheumatoid arthritis, scleroderma, end stage renal disease, chronic obstructive pulmonary disease, chronic regional pain syndrome, multiple sclerosis, hypersensitivity to cold, or patients on chemotherapy

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2015

Estimated Enrollment :

197 Patients enrolled

Trial Details

Trial ID

NCT01509599

Start Date

August 1 2011

End Date

December 1 2015

Last Update

April 5 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

2

Spartanburg Regional Medical Center

Spartanburg, South Carolina, United States, 29303